Search results
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis...
Medical Xpress· 21 hours agoThe findings lay the groundwork to identify therapeutic targets in non-clear-cell renal cell carcinomas. Renal < ...
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients - British...
Nature· 3 days agoTregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in ...
Afinitor interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoAfinitor has interactions with some other drugs and certain supplements. Before you start treatment...
Good to Know: Grim diagnosis spurs Kent couple to sell possessions, plan RV trip of a lifetime
Akron Beacon Journal via Yahoo News· 1 day agoBut a scan last summer found new growth and Dailey had surgery to remove tumors on the kidney. And...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 1 day agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 24 hours agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 5 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 6 days agoCabometyx (cabozantinib) generated revenues of $376.4 million, which missed the Zacks Consensus...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Unknown risk factor linked to high rates of kidney cancer, DNA study finds
Medical Xpress· 5 days agoIn a paper published in Nature, scientists from the Mutographs Cancer Grand Challenges team, based at the Wellcome Sanger Institute, the International Agency for Research on Cancer, and a large ...